TPD & Induced Proximity Summit Leaderboard
  • Thursday, July 23, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 597

Author

Pharma Journalist 8947 posts 0 comments

Key Opinion Leaders to Present at the Respiratory Drug Delivery Conference

Aug 12, 2019
SMi Reports: Learn from key opinion leaders at the Respiratory Drug Delivery conference this December SMi Group are delighted to announce their inaugural conference Respiratory Drug…
Read More...

Neoleukin Therapeutics and Aquinox Pharmaceuticals Complete Merger Transaction

Aug 12, 2019
Neoleukin Therapeutics, Inc. announced the completion of the previously disclosed merger transaction with Aquinox Pharmaceuticals, Inc. Aquinox Pharmaceuticals, Inc. will be renamed…
Read More...

Amgen Wins Patent Case On Enbrel (etanercept)

Aug 12, 2019
Amgen announced that the U.S. District Court for the District of New Jersey has ruled in Amgen's favor on validity of the two patents that describe and claim Enbrel (etanercept) and…
Read More...

Cancer Research UK and Hummingbird Bioscience join forces to advance novel antibody drug into…

Aug 9, 2019
Cancer Research UK, the world’s leading cancer charity, and Hummingbird Bioscience, an innovative systems-biology enabled biotechnology company, have announced a partnership to develop…
Read More...

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

Aug 9, 2019
Bayer AG and BlueRock Therapeutics announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered biotechnology company focused on…
Read More...

Takeda Submits NDA for a Subcutaneous Formulation of Vedolizumab for Patients with Moderately to…

Aug 9, 2019
Takeda Pharmaceutical Company Limited announced that it has submitted a New Drug Application (NDA) to the Ministry of Health, Labour and Welfare in Japan for a subcutaneous (SC)…
Read More...

New lung cancer treatment option approved by NICE

Aug 9, 2019
Immunotherapy drug pembrolizumab (also known as Keytruda) used with chemotherapy drugs carboplatin and paclitaxel will now be an option for adults with squamous non-small-cell lung…
Read More...

Big Pharma are investing huge amounts in data analytics, but what are the challenges and…

Aug 9, 2019
In 2018, return on investment for R&D in big pharma companies fell to just 3.7% creating a huge problem for the industry. Big pharma have there been forced to find solutions and are…
Read More...

Dynacure Receives Orphan Drug Designation from the FDA for DYN101

Aug 8, 2019
Dynacure, a clinical stage drug development company focused on improving the lives of patients with rare and orphan disorders, announced that the U.S. Food and Drug Administration (FDA)…
Read More...

Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash

Aug 8, 2019
Cambrex Corporation, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, announced that it has signed a…
Read More...
Prev Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Organon Expands Australia Biosimilar Partnership With Samsung Bioepis
  • Telix Opens Advanced Cancer Radiopharmaceutical Facility in Melbourne
  • FDA Approves First Oral PCSK9 Inhibitor for High Cholesterol
  • FDA Grants Full Approval to Fabhalta for IgA Nephropathy
  • EU Approves Wegovy Pill for Obesity Treatment

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.